High Tower Advisors, LLC Moderna, Inc. Transaction History

High Tower Advisors, LLC

$71.6 Billion
Q4 2024

A detailed history of High Tower Advisors, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 32,739 shares of MRNA stock, worth $991,009. This represents 0.0% of its overall portfolio holdings.

Number of Shares

32,739

Previous 34,739 5.76%

Holding current value

$991,009

Previous $2.32 Million 41.36%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	SELL	$36.85 - $63.93 $73,700 - $127,860	-2,000 Reduced 5.76%	32,739 $1.36 Million
Q3 2024 Nov 14, 2024	SELL	$63.64 - $125.14 $893,505 - $1.76 Million	-14,040 Reduced 28.78%	34,739 $2.32 Million
Q2 2024 Aug 13, 2024	SELL	$101.21 - $166.61 $1.36 Million - $2.23 Million	-13,397 Reduced 21.55%	48,779 $5.79 Million
Q1 2024 May 06, 2024	BUY	$85.37 - $115.44 $370,505 - $501,009	4,340 Added 7.5%	62,176 $6.63 Million
Q4 2023 Feb 12, 2024	SELL	$69.51 - $104.43 $103,778 - $155,913	-1,493 Reduced 2.52%	57,836 $5.75 Million
Q3 2023 Nov 08, 2023	BUY	$96.41 - $126.61 $1.45 Million - $1.91 Million	15,077 Added 34.07%	59,329 $6.13 Million
Q2 2023 Aug 14, 2023	BUY	$118.5 - $160.53 $777,004 - $1.05 Million	6,557 Added 17.39%	44,252 $5.38 Million
Q1 2023 May 11, 2023	SELL	$135.66 - $197.02 $254,498 - $369,609	-1,876 Reduced 4.74%	37,695 $5.79 Million
Q4 2022 Feb 08, 2023	SELL	$118.38 - $210.04 $3.88 Million - $6.88 Million	-32,773 Reduced 45.3%	39,571 $7.11 Million
Q3 2022 Nov 09, 2022	BUY	$118.07 - $194.18 $1.09 Million - $1.79 Million	9,227 Added 14.62%	72,344 $8.55 Million
Q2 2022 Aug 10, 2022	BUY	$117.13 - $176.59 $3.67 Million - $5.54 Million	31,367 Added 98.79%	63,117 $9.02 Million
Q1 2022 May 12, 2022	SELL	$126.46 - $235.05 $953,508 - $1.77 Million	-7,540 Reduced 19.19%	31,750 $5.46 Million
Q4 2021 Feb 10, 2022	SELL	$225.82 - $368.51 $2.52 Million - $4.12 Million	-11,177 Reduced 22.15%	39,290 $9.98 Million
Q3 2021 Nov 12, 2021	SELL	$221.9 - $484.47 $758,676 - $1.66 Million	-3,419 Reduced 6.34%	50,467 $19.4 Million
Q2 2021 Aug 06, 2021	BUY	$129.91 - $234.98 $1.16 Million - $2.1 Million	8,940 Added 19.89%	53,886 $12.7 Million
Q1 2021 May 10, 2021	BUY	$109.18 - $185.98 $1.25 Million - $2.13 Million	11,438 Added 34.14%	44,946 $5.89 Million
Q4 2020 Feb 10, 2021	SELL	$65.74 - $169.86 $170,792 - $441,296	-2,598 Reduced 7.2%	33,508 $3.49 Million
Q3 2020 Nov 13, 2020	BUY	$54.34 - $94.85 $758,532 - $1.32 Million	13,959 Added 63.03%	36,106 $2.55 Million
Q2 2020 Aug 10, 2020	BUY	$29.67 - $80.0 $348,325 - $939,200	11,740 Added 112.81%	22,147 $1.42 Million
Q1 2020 May 21, 2020	BUY	$17.78 - $31.58 $185,036 - $328,653	10,407 New	10,407 $312,000

Others Institutions Holding MRNA

# of Institutions

925

Shares Held

256M

Call Options Held

19M

Put Options Held

24.3M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $11.8B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Account

High Tower Advisors, LLC Moderna, Inc. Transaction History